Antisense Pharma Gets $39.5M For Antisense Glioma Product Nov. 14, 2007 By Cormac Sheridan Antisense Pharma GmbH raised €27 million (US$39.5 million) in a third investment round funded solely by MIG AG, which also was the only investor in its €18 million funding round two years ago. (BioWorld International)Read More
Cerep Sells Hesperion To CRO Averion In €25M Deal Nov. 14, 2007 By James Etheridge No AbstractRead More
RSS